Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes

By sjmartinez • April 15, 2025

Zelada H, Campana M, Kawai K, Redden D, Agarwal G, Gutierrez OM, Kumar V. Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes. Clin Transplant. 2025 Apr;39(4):e70144. doi: 10.1111/ctr.70144. PMID: 40230336.

Tags: allograft, diabetes, DOM STAT, Endocrinology, Function, General Internal Medicine, kidney, kidney (allograft) function, posttransplant, Publications

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness

Perini Villanueva G, Solorzano WM, Everett E. Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness. Curr Diab Rep. 2026[...]

Spatial transcriptome mapping identifies Ppara-Anxa2 cross-talk in microplastic-induced hepatotoxicity

Jung W, Abushukair H, Patil NY, Ampadu F, Firouzi M, Rus I, Choi J, Muthukrishnan SD, Shukla S, Tarantini S, Csiszar A, Mehla K, Kim[...]

Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson’s disease

Sheshadri P, Costa-Besada MA, Fisher A, Kiraly S, Singh K, Kourouzidou I, Blacker TS, Zeng J, Shirihai OS, Grinstaff MW, Duchen MR. Targeting lysosomal pH[...]